Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoia Antysheva

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|July 31, 2025
Machine learning-based single-sample molecular classifier for cancer gradingZoia Antysheva, Nikita Kotlov, Mariia V Guryleva, et al.
International Journal of Molecular Sciences|October 26, 2024
Molecular Basis of Pancreatic Neuroendocrine TumorsAlesia Maluchenko, Denis Maksimov, Zoia Antysheva, et al.
Journal of Cancer Research and Clinical Oncology|December 31, 2024
Case study of a neuroendocrine tumor of uncertain origin: single-cell transcriptomics unravels potential primary locationFrolova Tatyana, Ekaterina Avsievich, Diana Salimgereeva, et al.
Human Genetics|December 2, 2025
MutAnt: mutation annotation tool predicts deleteriousness of missense mutations and improves mutation calling from transcriptomicsAleksandr Sarachakov, Anastasiya Yudina, Viktor Svekolkin, et al.
Journal of Clinical Medicine|January 8, 2025
Pancreatic Neuroendocrine Tumor: The Case Report of a Patient with Germline <i>FANCD2</i> Mutation and Tumor Analysis Using Single-Cell RNA SequencingEkaterina Avsievich, Diana Salimgereeva, Alesia Maluchenko, et al.
International Journal of Molecular Sciences|July 29, 2025
A Case of Salt-Wasting Congenital Adrenal Hyperplasia Caused by a Rare Intronic Variant in the <i>CYP21A2</i> GeneZoia Antysheva, Anton Esibov, Ekaterina Avsievich, et al.
NPJ Breast Cancer|February 20, 2025
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtypePolina Turova, Vladimir Kushnarev, Oleg Baranov, et al.
Cells|December 24, 2025
Karyotypic Profiling of Induced Pluripotent Stem Cells Derived from a Xeroderma Pigmentosum Group C PatientAlmaqdad Alsalloum, Natalia Mingaleva, Ekaterina Gornostal, et al.
Frontiers in Oncology|February 6, 2024
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysisMajd Al Assaad, Nara Shin, Michael Sigouros, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|July 31, 2025
Machine learning-based single-sample molecular classifier for cancer gradingZoia Antysheva, Nikita Kotlov, Mariia V Guryleva, et al.
International Journal of Molecular Sciences|October 26, 2024
Molecular Basis of Pancreatic Neuroendocrine TumorsAlesia Maluchenko, Denis Maksimov, Zoia Antysheva, et al.
Journal of Cancer Research and Clinical Oncology|December 31, 2024
Case study of a neuroendocrine tumor of uncertain origin: single-cell transcriptomics unravels potential primary locationFrolova Tatyana, Ekaterina Avsievich, Diana Salimgereeva, et al.
Human Genetics|December 2, 2025
MutAnt: mutation annotation tool predicts deleteriousness of missense mutations and improves mutation calling from transcriptomicsAleksandr Sarachakov, Anastasiya Yudina, Viktor Svekolkin, et al.
Journal of Clinical Medicine|January 8, 2025
Pancreatic Neuroendocrine Tumor: The Case Report of a Patient with Germline <i>FANCD2</i> Mutation and Tumor Analysis Using Single-Cell RNA SequencingEkaterina Avsievich, Diana Salimgereeva, Alesia Maluchenko, et al.
International Journal of Molecular Sciences|July 29, 2025
A Case of Salt-Wasting Congenital Adrenal Hyperplasia Caused by a Rare Intronic Variant in the <i>CYP21A2</i> GeneZoia Antysheva, Anton Esibov, Ekaterina Avsievich, et al.
NPJ Breast Cancer|February 20, 2025
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtypePolina Turova, Vladimir Kushnarev, Oleg Baranov, et al.
Cells|December 24, 2025
Karyotypic Profiling of Induced Pluripotent Stem Cells Derived from a Xeroderma Pigmentosum Group C PatientAlmaqdad Alsalloum, Natalia Mingaleva, Ekaterina Gornostal, et al.
Frontiers in Oncology|February 6, 2024
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysisMajd Al Assaad, Nara Shin, Michael Sigouros, et al.
Pageof 1